SANJIVANI PARANTERAL
Back to All Ratios
|
SANJIVANI PARANTERAL Last 5 Year EBIT Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EBIT Growth(%) | 39.87 | - |
What is the latest EBIT Growth ratio of SANJIVANI PARANTERAL ?
| Year | EBIT Growth |
|---|---|
| Mar2025 | 39.87 |
| Mar2024 | - |
How is EBIT Growth of SANJIVANI PARANTERAL Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2025 | 39.87 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of SANJIVANI PARANTERAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹222.8 Cr | 9.7% | -2.7% | -19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 9.7% |
-2.7% |
-19.7% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses